Background: Community-acquired pneumonia (CAP) remains an important cause of morbidity and mortality in industrialized countries. The need to estimate regional incidence and prevalence of the disease with its diverse etiology is justified by the shifting patterns and rising incidence of CAP. Thus, the present study was conducted to determine the etiology, risk factors and outcome in hospitalized patients with community acquired pneumonia at our institute Material and methods:300 patients with presumed pneumonia; presenting with symptoms of acute respiratory infection in the emergency department, medicine ward and intensive care unit(ICU).A thorough demographic history and clinical history were obtained in the pre-designed study proforma. The clinical examination was done at the time of presentation and investigations which are part of evaluation like hemogram, metabolic profile, chest X-ray, radio-imaging, etc. was done. Outcome of the patient was assessed at the time of discharge Results:Mean age of the patients was 52.85 years. Among 78 percent of the patients, the etiology was COVID 19. In 10 percent of the patients, CAP was of bacteriological etiology (Klebsiella) while 2.67 percent of the patients with CAP had viral etiology (Influenza A H1N1). Tuberculous etiology was seen in 5 percent of the patients while etiology was unknown in 4 percent of the patients. Mortality rate among patients with COVID-19 etiology was significant higher in comparison to patients with other etiologies. Conclusion: Long recognized as a major cause of death, CAP has been studied intensively since decades ago, the result of which led to many formative insights in modern microbiology, despite this research and the development of anti-microbial agents, pneumonia remains a major cause of complications and death